- Home
- LYB vs FMS Comparison
LYB vs FMS Comparison
Compare LYB & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYB
- FMS
- Stock Information
- Founded
- LYB 1955
- FMS 1996
- Country
- LYB United States
- FMS Germany
- Employees
- LYB N/A
- FMS N/A
- Industry
- LYB Major Chemicals
- FMS Misc Health and Biotechnology Services
- Sector
- LYB Industrials
- FMS Health Care
- Exchange
- LYB Nasdaq
- FMS Nasdaq
- Market Cap
- LYB 18.5B
- FMS 15.9B
- IPO Year
- LYB N/A
- FMS 1996
- Fundamental
- Price
- LYB $62.58
- FMS $28.35
- Analyst Decision
- LYB Hold
- FMS Hold
- Analyst Count
- LYB 13
- FMS 1
- Target Price
- LYB $68.62
- FMS $30.00
- AVG Volume (30 Days)
- LYB 4.3M
- FMS 383.3K
- Earning Date
- LYB 08-01-2025
- FMS 07-29-2025
- Dividend Yield
- LYB 8.76%
- FMS 2.01%
- EPS Growth
- LYB N/A
- FMS 27.83
- EPS
- LYB 3.25
- FMS 2.28
- Revenue
- LYB $39,675,000,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- LYB N/A
- FMS $2.74
- Revenue Next Year
- LYB $2.93
- FMS $3.60
- P/E Ratio
- LYB $19.22
- FMS $24.99
- Revenue Growth
- LYB 1.30
- FMS 0.10
- 52 Week Low
- LYB $51.11
- FMS $17.93
- 52 Week High
- LYB $100.46
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- LYB 62.56
- FMS 53.64
- Support Level
- LYB $57.48
- FMS $26.16
- Resistance Level
- LYB $59.50
- FMS $28.87
- Average True Range (ATR)
- LYB 1.58
- FMS 0.39
- MACD
- LYB 0.34
- FMS 0.03
- Stochastic Oscillator
- LYB 95.13
- FMS 75.26
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.